Cargando…

Using Procalcitonin to Guide Antibiotic Escalation in Patients With Suspected Bacterial Infection: A New Application of Procalcitonin in the Intensive Care Unit

BACKGROUND: Procalcitonin (PCT) is efficient in reducing antibiotic usage without increasing complications for its sensitivity and specificity in detecting bacterial infection. However, its role in guiding antibiotic-spectrum escalation has not been studied. This study was performed to validate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xu, Long, Yun, Su, Longxiang, Zhang, Qing, Shan, Guangliang, He, Huaiwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964283/
https://www.ncbi.nlm.nih.gov/pubmed/35360102
http://dx.doi.org/10.3389/fcimb.2022.844134
_version_ 1784678179817914368
author Wang, Xu
Long, Yun
Su, Longxiang
Zhang, Qing
Shan, Guangliang
He, Huaiwu
author_facet Wang, Xu
Long, Yun
Su, Longxiang
Zhang, Qing
Shan, Guangliang
He, Huaiwu
author_sort Wang, Xu
collection PubMed
description BACKGROUND: Procalcitonin (PCT) is efficient in reducing antibiotic usage without increasing complications for its sensitivity and specificity in detecting bacterial infection. However, its role in guiding antibiotic-spectrum escalation has not been studied. This study was performed to validate the role of PCT in indicating antibiotic spectrum escalation when pathogen results are unknown for ICU patients of suspected bacterial infections. METHODS: This was a single-center retrospective study including patients who were admitted to Peking Union Medical College Hospital from January 2014 to June 2018 for suspected bacterial infections. Patients were divided into “escalation” or “non-escalation” groups according to the change of employed antibiotic spectrum before and after the occurrence of “PCT alert”. The main study endpoint was the length of ICU stay (LIS), and LIS longer than 7 days was defined as “prolonged-ICU-stay (PIS)” while LIS equal to or shorter than 7 days was defined as “non-prolonged-ICU-stay(nPIS)”. Demographics, clinical characteristics, and infection characteristics were compared between patients in the “nPIS” and “PIS” groups. Multivariable logistic regression was used to evaluate independent risk factors for PIS. RESULTS: Totally, 1109 patients were included, and 654 in the PIS group, other 455 in the nPIS group. Respiratory infection was the main cause in both groups. Patients were older in PIS group than in nPIS group(PIS vs. nPIS: 58.99 ± 16.30 vs. 56.12 ± 15.93 years, P=0.002). The baseline Sequential Organ Failure Assessment (SOFA) score was 11.16 ± 7.33 and 9.73 ± 3.70 in PIS and nPIS groups. Fewer patients received antibiotic escalation in face of “PCT alert” in PIS group (PIS vs. nPIS: 27.68 vs.35.38%, P=0.014). In the multivariable logistic regression model, older age, higher heart rate, not undergoing surgery, higher baseline SOFA score, and not escalating antibiotics in face of “PCT alert” were associated with a prolonged ICU stay. The odds ratio of antibiotic escalation for PIS was 0.582 (95% CI: 0.365, 0.926, P=0.022). CONCLUSIONS: Using PCT to guide antibiotic escalation when pathogen evidence is unavailable could be associated with a shorter length of ICU stay for ICU patients of suspected bacterial infection.
format Online
Article
Text
id pubmed-8964283
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89642832022-03-30 Using Procalcitonin to Guide Antibiotic Escalation in Patients With Suspected Bacterial Infection: A New Application of Procalcitonin in the Intensive Care Unit Wang, Xu Long, Yun Su, Longxiang Zhang, Qing Shan, Guangliang He, Huaiwu Front Cell Infect Microbiol Cellular and Infection Microbiology BACKGROUND: Procalcitonin (PCT) is efficient in reducing antibiotic usage without increasing complications for its sensitivity and specificity in detecting bacterial infection. However, its role in guiding antibiotic-spectrum escalation has not been studied. This study was performed to validate the role of PCT in indicating antibiotic spectrum escalation when pathogen results are unknown for ICU patients of suspected bacterial infections. METHODS: This was a single-center retrospective study including patients who were admitted to Peking Union Medical College Hospital from January 2014 to June 2018 for suspected bacterial infections. Patients were divided into “escalation” or “non-escalation” groups according to the change of employed antibiotic spectrum before and after the occurrence of “PCT alert”. The main study endpoint was the length of ICU stay (LIS), and LIS longer than 7 days was defined as “prolonged-ICU-stay (PIS)” while LIS equal to or shorter than 7 days was defined as “non-prolonged-ICU-stay(nPIS)”. Demographics, clinical characteristics, and infection characteristics were compared between patients in the “nPIS” and “PIS” groups. Multivariable logistic regression was used to evaluate independent risk factors for PIS. RESULTS: Totally, 1109 patients were included, and 654 in the PIS group, other 455 in the nPIS group. Respiratory infection was the main cause in both groups. Patients were older in PIS group than in nPIS group(PIS vs. nPIS: 58.99 ± 16.30 vs. 56.12 ± 15.93 years, P=0.002). The baseline Sequential Organ Failure Assessment (SOFA) score was 11.16 ± 7.33 and 9.73 ± 3.70 in PIS and nPIS groups. Fewer patients received antibiotic escalation in face of “PCT alert” in PIS group (PIS vs. nPIS: 27.68 vs.35.38%, P=0.014). In the multivariable logistic regression model, older age, higher heart rate, not undergoing surgery, higher baseline SOFA score, and not escalating antibiotics in face of “PCT alert” were associated with a prolonged ICU stay. The odds ratio of antibiotic escalation for PIS was 0.582 (95% CI: 0.365, 0.926, P=0.022). CONCLUSIONS: Using PCT to guide antibiotic escalation when pathogen evidence is unavailable could be associated with a shorter length of ICU stay for ICU patients of suspected bacterial infection. Frontiers Media S.A. 2022-03-14 /pmc/articles/PMC8964283/ /pubmed/35360102 http://dx.doi.org/10.3389/fcimb.2022.844134 Text en Copyright © 2022 Wang, Long, Su, Zhang, Shan and He https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Wang, Xu
Long, Yun
Su, Longxiang
Zhang, Qing
Shan, Guangliang
He, Huaiwu
Using Procalcitonin to Guide Antibiotic Escalation in Patients With Suspected Bacterial Infection: A New Application of Procalcitonin in the Intensive Care Unit
title Using Procalcitonin to Guide Antibiotic Escalation in Patients With Suspected Bacterial Infection: A New Application of Procalcitonin in the Intensive Care Unit
title_full Using Procalcitonin to Guide Antibiotic Escalation in Patients With Suspected Bacterial Infection: A New Application of Procalcitonin in the Intensive Care Unit
title_fullStr Using Procalcitonin to Guide Antibiotic Escalation in Patients With Suspected Bacterial Infection: A New Application of Procalcitonin in the Intensive Care Unit
title_full_unstemmed Using Procalcitonin to Guide Antibiotic Escalation in Patients With Suspected Bacterial Infection: A New Application of Procalcitonin in the Intensive Care Unit
title_short Using Procalcitonin to Guide Antibiotic Escalation in Patients With Suspected Bacterial Infection: A New Application of Procalcitonin in the Intensive Care Unit
title_sort using procalcitonin to guide antibiotic escalation in patients with suspected bacterial infection: a new application of procalcitonin in the intensive care unit
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964283/
https://www.ncbi.nlm.nih.gov/pubmed/35360102
http://dx.doi.org/10.3389/fcimb.2022.844134
work_keys_str_mv AT wangxu usingprocalcitonintoguideantibioticescalationinpatientswithsuspectedbacterialinfectionanewapplicationofprocalcitoninintheintensivecareunit
AT longyun usingprocalcitonintoguideantibioticescalationinpatientswithsuspectedbacterialinfectionanewapplicationofprocalcitoninintheintensivecareunit
AT sulongxiang usingprocalcitonintoguideantibioticescalationinpatientswithsuspectedbacterialinfectionanewapplicationofprocalcitoninintheintensivecareunit
AT zhangqing usingprocalcitonintoguideantibioticescalationinpatientswithsuspectedbacterialinfectionanewapplicationofprocalcitoninintheintensivecareunit
AT shanguangliang usingprocalcitonintoguideantibioticescalationinpatientswithsuspectedbacterialinfectionanewapplicationofprocalcitoninintheintensivecareunit
AT hehuaiwu usingprocalcitonintoguideantibioticescalationinpatientswithsuspectedbacterialinfectionanewapplicationofprocalcitoninintheintensivecareunit